Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT05854303
Status
Recruiting

Conditions

  • Opioid-Induced Esophageal Dysfunction

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Opioid cessation — BEHAVIORAL
    opioid cessation will occur during pain rehabilitative program over approximately 3 weeks
  • No opioid cessation — OTHER
    Subjects will not stop taking opioids

Study Details

The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).

Key Dates

Start date
Sep 18, 2023
Status verified
Oct 2025
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
26 participants (estimated)

Arms

  • Arm: Opioid Cessation
    Subjects able to complete opioid cessation.
  • Arm: Non-Opioid Cessation
    Subjects unable to complete opioid cessation.

Primary Outcome Measure

Number of subjects to have opioid-induced esophageal dysfunction resolution [ Time Frame: 4 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic MinnesotaRochesterMinnesota55905-

Find similar trials in Rochester, MN